AbbVie Inc. — Director's Dealing 2023

May 2, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2023-04-28

Reporting Person: TILTON GLENN F (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-04-28	Stock Equivalent Units	$151.12	M	2230	Disposed		Common Stock (2230)	Direct

Footnotes

F1: The cash equivalent of 2,230 AbbVie stock equivalent units in the Abbott account was paid to the director upon his retirement from Abbott's board on April 28, 2023.

F2: Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.